Form 4 for CORT CORCEPT THERAPEUTICS INC
Accepted 2025-11-05 00:00:00 ET · period of report 2025-11-03 · accession 0001193125-25-267548 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-11-05 | 2025-11-03 | CORT | Lyon Joseph Douglas | See Remarks | S - Sale+OE | $73.65 | -5,000 | 10.3K | -33% | -$368.2K |
| DT | 2025-11-05 | 2025-11-03 | CORT | Lyon Joseph Douglas | See Remarks | M - OptEx | $13.56 | +5,000 | 15.3K | +49% | +$67.8K |
| DT | 2025-11-05 | 2025-11-03 | CORT | Lyon Joseph Douglas | See Remarks | M - OptEx | $0.00 | -5,000 | 16.6K | -23% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-03 | S | D | 5,000 | $73.65 | 10,277 | D | — | — | (F3) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $73.47 to $73.945 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. (F1) Includes 215 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 216 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 749 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. |
| 2 | Common | Common Stock | 2025-11-03 | M | A | 5,000 | $13.56 | 15,277 | D | — | — | (F1) Includes 215 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 216 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 749 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. |
| 3 | Derivative | Stock option (right to buy) | 2025-11-03 | M | D | 5,000 | $0.00 | 16,571 | D | $13.56 · — to 2030-02-07 | 5,000 Common Stock | (F4) Fully exercisable. |